•
Dec 31, 2021

Prelude Therapeutics Q4 2021 Earnings Report

EPS
-$0.71
Previous year: -$0.45
+57.8%
Cash and Equivalents
$31.8M
Free Cash Flow
-$26M
Total Assets
$305M

Prelude Therapeutics

Prelude Therapeutics